Published in Gene Therapy Weekly, May 12th, 1997
"The CDR-based peptides are potential candidates for therapy of SLE," reported Ari Waisman and colleagues of The Weizmann Institute of Science, Rehovot 76100, Israel ("Modulation of Murine Systemic Lupus Erythematosus with Peptides Based on Complementarity Determining Regions of a Pathogenic Anti-DNA Monoclonal Antibody," PNAS, 1997;94:4620-5).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.